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ABSTRACT  The binding of nerve growth factor (NGF) to specific cell surface  receptors initiates 
a variety of effects  that lead  to the  morphological  and  biochemical  differentiation  of clonal 
pheochromocytoma,  PC12, cells.  The lectin wheat germ agglutinin  (WGA) alters the charac- 
teristics of NGF-receptor interaction. We have found that treatment of PC12 cells with WGA 
dramatically and reversibly inhibits the ability of NGF to elicit three distinct biological effects 
characteristic of NGF action. Two of these events,  the rapid ruffling of cell-surface membranes 
and  the  stimulation  of the  phosphorylation  of a 250-kD  cytoskeletal  protein  in  situ,  occur 
rapidly and are an immediate consequence of receptor occupancy.  Both of these effects are 
blocked  by pretreatment  of the cells  with  WGA.  WGA was also  found  to  inhibit the  NGF- 
stimulated regeneration of neurites that occurs over 1-2 d. Both the WGA inhibition of neurite 
outgrowth  and the  phosphorylation  of the 250-kD cytoskeletal  protein were reversed  upon 
addition  of the specific  sugar N-acetylglucosamine.  These  data demonstrate that the WGA- 
induced  changes  in the  NGF-receptor  interaction  reflect  important alterations  in the ability 
of the  receptor  to  transmit  biological  signals, resulting  in  the  abrogation  of the  biological 
effects of NGF on these cells. 
Nerve growth factor (NGF) ~ directs the morphological and 
biochemical differentiation of sympathetic and certain sen- 
spry neurons (1). The cellular mechanisms that subserve NGF 
action on its target cells are unknown. The clonal rat pheo- 
chromocytoma line, PC12, responds to NGF by ceasing di- 
vision and acquiring various phenotypic characters similar to 
those of sympathetic neurons (2, 3). This cell line has proven 
to be a  valuable model for investigating the mechanism of 
NGF action. 
PC12 cells have two interconvertible classes of cell-surface 
receptors for NGF (4-7). The two receptor populations can 
be distinguished based on their different kinetic properties, 
sensitivity  to  trypsin  digestion,  and  solubility  in  nonionic 
detergents. One class of receptors demonstrates rapid disso- 
ciation kinetics and has been termed the "fast" receptors; this 
population  of receptors is  trypsin-labile and  is  solubilized 
upon extraction of PC 12 cells in Triton X-100 (5). A second 
class  of receptors,  or  "slow"  receptors,  from  which  NGF 
dissociates slowly, is trypsin-stable and remains with the Tri- 
ton-insoluble cytoskeleton after detergent extraction  of the 
cells. The latter class of NGF receptors appears to be respon- 
Abbreviations used in this paper.  NGF, nerve growth factor; WGA, 
wheat germ agglutinin. 
sible for the internalization of the NGF-receptor complex (8), 
and based on the NGF dose-dependence of various biological 
effects is likely to mediate many of the actions of NGF on 
these cells (3). Some controversy exists as to whether the two 
populations of receptors preexist on the  cell  surface or are 
generated as a  consequence of ligancf-dependent conversion 
of "fast"  to  "slow"  receptors  (4,  5);  it  is  also  unresolved 
whether the  two  classes of receptors demonstrate different 
equilibrium dissociation constants (5, 7, 8). 
The NGF receptor is a membrane glycoprotein of at least 
85  kD; other species of -150  and  200  kD have also been 
identified (9-13). The NGF receptor has N-acetylglucosamine 
residues that bind the lectin wheat germ agglutinin (WGA) 
(10).  It is interesting that binding of the lectin has dramatic 
effects on the interaction of NGF with its receptor (10,  14- 
16). WGA treatment of PC12 cells induces the conversion of 
kinetically "fast" receptors to "slow" receptors, confers tryp- 
sin-resistance to the hormone-receptor complex, and results 
in the association of the NGF-receptor complexes with the 
Triton-insoluble  cytoskeleton.  These  effects  are  reversible 
upon dissociation of WGA from the receptor by the addition 
of the specific sugar, N-acetylglucosamine. 
Although the ability of WGA to alter the binding charac- 
teristics of the NGF receptor has been well characterized, the 
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NGF to produce its specific effects on these cells has not been 
examined. We report here that the interaction of WGA with 
the NGF receptor abrogates the ability of NGF to elicit three 
distinct biological effects characteristic of NGF action on these 
cells.  The inhibition of NGF action is reversible and specific 
for WGA. 
MATERIALS  AND  METHODS 
Materials:  WGA was purchased from  Calbiocbem-Behring Corp,  (San 
Diego,  CA).  NGF was prepared by the method of Smith et al.  (17).  Horse 
serum was obtained from  KC Biologicals Inc. (Lenexa,  KS), fetal calf serum 
from Gibco Laboratories Inc. (Grand Island, NY). The lectins Dolichos biflorus 
agglutinin, peanut agglutinin, and concanavalin A were from Sigma Chemical 
Co. (St. Louis, MO). 
Cell Culture:  PCl2 cells were grown in an atmosphere of 10% CO2 in 
Dulbecco's modified Eagle's medium containing 10% horse serum, 5%  fetal 
calf serum. 
Measurement  of Neurite  Outgrowth:  Neurite outgrowth was 
measured using the bioassay of Greene 08). PCI2 cells were treated for l I d 
with 50 ng/ml NGF,  with the medium being changed every 2 d. The cells were 
removed from  the tissue culture dish by trituration, washed,  and replated in 
polylysine-treated  16-mm tissue culture wells in serum-free medium containing 
l  mg/ml bovine serum albumin. NGF was added at a final concentration of 
50 ng/ml along with lectins or N-acetylglucosamine  as indicated. The cellular 
aggregates were examined 24 h later for neurite outgrowth,  and the fraction of 
neurite-bearing cellular aggregates  was determined.  After the cultures were 
scored,  some wells received  l0 mM N-acetylglucosamine  and were incubated 
for  24  h  more,  and  the  number  of neurite-bearing aggregates  was  again 
determined. The assay was performed using triplicate wells with at least 80 
aggregates counted per well. 
Phosphorylation  of PC12 Cytoskeletal  Proteins  In Situ:  The 
phosphorylation of PCI2 cytoskeletal protein was performed as described  by 
Landreth and Rieser (19).  PC12  cells were  removed from  the tissue culture 
dishes by trituration in calcium- and magnesium-free  phosphate-buffered  saline 
(PBS), washed,  and then resuspended at a final concentration of l0  s cells/ml 
in PBS containing l  mg/ml bovine serum albumin and 1 mg/ml glucose. The 
cells were  incubated at 37"C in the presence  of 50 ng/ml NGF or lectin,  as 
indicated. The cells were collected by centrifugation and extracted in 0.15% 
Triton X-100, 25 mM HEPES, pH 7.4, 2 mM MnCl2, and l mM phenylmeth- 
ylsulfonyl fluoride for 2 rain at 4"C. The resulting cytoskeletons were pelleted 
by centrifugation for 30 s in a Beckman Microfuge  B (Beckman Instruments 
Inc.,  Palo Alto, CA) and resuspended in the same buffer  but without Triton. 
The phosphorylation reaction was initiated by the addition of [32P]ATP (I0 
~M,  50 dpm/fmol ATP) and carried out for  10 min at 4"C. The reaction was 
stopped by the addition of electrophoresis  sample buffer and 5 min of boiling. 
The labeled cytoskeletal proteins were separated by electrophoresis on 4-13% 
polyacrylamide  gels as described  by Laemmli (20). The gels were stained with 
0. 1% Coomassic Blue, dried, and exposed to Kodak XAR film. 
Scanning  Electron  Microscopy:  PCl2 cells were grown on poly- 
lysine-treated glass  coverslips.  The  cells  were  then  incubated in  serum-free 
medium in the presence  of 50 ng/ml NGF or 50 ttg/ml WGA.  WGA-treated 
samples were incubated for 30 rain at 37°C; one group of cells was preincubated 
with WGA but then received NGF and was incubated for 3 min more at 37"C. 
The NGF-treated samples were incubated for 3 min at 37"C. The treatment 
was terminated by a  rapid wash  with cold PBS  followed  by fixation in 2% 
glutaraldehyde for  5  min at room temperature. The cells were washed  with 
PBS, postfixed  in  1%  osmium tetroxide for 3 min, washed  extensively,  and 
dehydrated through graded alcohols.  The samples were  critical point dried, 
coated with gold-palladium,  and examined using a JEOL 35C scanning electron 
microscope. The figures are representative  of triplicate samples with ~200 cells 
examined per sample. 
RESULTS 
Effect of WGA on NGF-stimulated 
Neurite Outgrowth 
NGF treatment  of PC12  cells  produces transcriptionally 
based events, termed "priming," which lead to morphological 
differentiation with the growth of extensive neuritic processes 
over a period of several days (2, 3). Once the PCI2 cells have 
been primed, if they are divested of their neurites by removal 
from the tissue culture dish and replated, they will regenerate 
their neurites in the presence of NGF. The fraction of PC12 
cells that exhibits neurites is NGF dose-dependent and is the 
basis of a sensitive bioassay for NGF (18). 
The ability of WGA to modify the effects of NGF on neurite 
regeneration was tested by incubating primed PCI2 cells with 
50 ng/ml NGF for 24 h in the presence or absence of WGA 
(Table I). WGA inhibited the NGF-induced neurite outgrowth 
in a  dose-dependent  manner, with half-maximal inhibition 
occurring at a WGA concentration of between 2.5 and 5 ~g/ 
ml.  This  effect  was abolished  by  inclusion  of the  specific 
sugar, N-acetylglucosamine, in the incubation. The effects of 
WGA were fully reversible, since the addition of 10 mM N- 
acetylglucosamine to the  cultures after a  24-h  exposure to 
WGA restored the ability of the cells to regenerate neurites. 
The  lectin-mediated  inhibition  of neurite  outgrowth was a 
specific  effect  of WGA,  as  concanavalin  A  and  Dolichos 
agglutinin were without effect (Table I). We have also been 
unable to inhibit neurite outgrowth with peanut agglutinin at 
doses as high as 50 ug/ml (data not shown). 
WGA Inhibits NGf-mediated Phosphorylation of 
a 250-kD Cytoskeletal Protein 
NGF treatment of PCI2 cells  produces stable changes in 
the cells that persist upon extraction of the ceils in nonionic 
detergent and that can be detected by phosphorylation of a 
250-kD cytoskeletal protein in situ (19). In this system, protein 
phosphorylation occurs between immobilized protein kinases 
and their protein substrates, both of which are associated with 
the detergent-insoluble cytoskeleton. The changes that lead to 
the phosphorylation of this protein occur rapidly after NGF 
TABLE  I,  Effect of Lectins on NGF-mediated Neurite Outgrowth 
%  with  neurites 
48 h 
(+10 mM 
24 h  GIcNac) 
mean (+_SD) 
Experiment  1 
NGF  95.7 (1.5)  97.1  (0.8) 
NGF +  2.5/~g/ml  WGA  67.7 (5.0)  95.5 (0.3) 
NGF +  5 ;zg/ml WGA  34.2 (1.7)  84.9 (1.8) 
NGF +  10 ~g/ml  WGA  9.5 (4.0)  64.8 (0.3) 
NGF +  10/~g/ml  WGA  +  10 mM  83.2 (5.8)  -- 
GIcNac 
No additions  11.6  9.8 (0.2) 
Experiment 2 
NGF  92.7 (2.2) 
NGF +  5 ug/ml  WGA  44,1  (7.0) 
NGF +  10 ug/ml  WGA  8.9 (1.8) 
NGF +  25/~g/ml  ConA  97.4 (1.9) 
NGF +  25/~g/ml  Dolichos biflorus  95.3 (0.5) 
agglutinin 
No additions  4.2 (1.3) 
PC12 cells were treated with  50 ng/ml  NGF for 11  d  and then replated in 
polylysine-treated wells in  serum-free medium  containing  1 mg]ml  bovine 
serum albumin.  NGF was added as indicated at a final concentration of 50 
ng/ml  alone or with  lectin.  The  fraction  of cellular aggregates  exhibiting 
neurite  outgrowth  was  determined  24  h  later.  At  this  time  10  mM  N- 
acetylglucosamine (GIcNac) was added to the indicated cultures, and neurite 
outgrowth was measured 24 h later. The data are the mean -SD of triplicate 
determinations. ConA, concanavalin A. 
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cytoskeletal protein. PC12 cells were preincubated for 30  min at 
37°C alone or with 50 #gJml of the indicated lectin. NGF was then 
added at a concentration of 50 ng/ml and incubated for 5 min more 
at 37°C.  The cells  were extracted in detergent-containing buffer 
and the resulting cytoskeletons were incubated for 10 min at 4°C 
with [32P]ATP. An autoradiogram of the labeled phosphoproteins is 
shown, and the position of the 250-kD protein is indicated. Lane a, 
untreated control. Other lanes were treated with: (lane  b)  NGF; 
(lane c) WGA then NGF; (lane d) concanavalin A then NGF; (lane 
e) peanut agglutinin then  NGF;  (lane  f)  Dolichos  agglutinin then 
NGF; (lane g) WGA then 10 mM N-acetylglucosamine and NGF. 
to the epidermal growth factor receptor, inhibiting the binding 
of the hormone (21). 
WGA Inhibits NGF Effects on 
Cell-Surface  Morphology 
The most immediate effect of NGF on PC 12 cells  is the 
dramatic alteration of cell-surface architecture (22).  The cell 
surface of PC 12 cells has numerous small blebs and microvilli; 
however, within  1 min of the addition of NGF large ruffles 
appear over the  dorsal  surface.  The  development of these 
ruffles occurs maximally within 2-4 min after NGF exposure. 
Treatment  of the  cells  with  50  ng/ml  NGF  for  3  rain 
resulted  in  the  appearance  of large  ruffles over the  dorsal 
surface of the cell (Fig.  3); these observations are similar to 
those previously reported by Connolly et  al.  (22).  If PCI2 
cells were pretreated for 30 min with WGA alone, the lectin 
had  no  significant  effect on  the  morphology of the  cells, 
although  very small blebs were frequently observed on the 
cell surface. Pretreatment of the cells with WGA for 30 rain, 
followed by the addition of NGF and a further incubation for 
3  min,  blocked  the  NGF-mediated changes  in  cell-surface 
architecture and development of ruffles. 
DISCUSSION 
The ability of the lectin WGA to modify the behavior of the 
NGF receptor has been extensively studied (10,  14-16),  yet 
the impact of these changes on the ability of the receptor to 
elicit biological responses has, until now, not been explored. 
We report here that whereas the binding of WGA to the NGF 
receptor results in the quantitative conversion of NGF recep- 
tors to the "slow" state, there is a dramatic inhibition of the 
ability of  the cells to respond to the hormone. This observation 
binding to  its receptors; however, the  phosphorylation is a 
transient  consequence  of hormone action,  occurring maxi- 
mally within  5  min of hormone exposure and  diminishing 
thereafter. 
Incubation of PC12 cells for 5 min at 37"C with 50 ng/ml 
NGF leads to the phosphorylation of the 250-kD protein in 
situ (Fig.  1). If the cells were pretreated for 30 rain at 37"C 
with  50 ~g/ml WGA, 50  ng/ml NGF was added,  and cells 
were incubated for 5 min more at 37"C, the 250-kD protein 
did  not  become  phosphorylated.  The  inhibitory  effect  of 
WGA was reversible; if at the end of the 30-min incubation 
with  WGA,  10  mM  N-acetylglucosamine was  added  with 
NGF, the effect of WGA on the phosphorylation of the 250- 
kD cytoskeletal protein was abolished.  Treating PC12  cells 
with Dolichos or peanut agglutinin or concanavalin A before 
NGF had no effect on the NGF-stimulated phosphorylation 
of the 250-kD cytoskeletal protein. 
The inhibition of 250-kD cytoskeletal protein phosphoryl- 
ation by WGA was dose-dependent; half-maximal inhibition 
occurred at a WGA concentration of ~5 gg/ml (Fig. 2). 
Similar experiments were performed to test if WGA would 
alter the ability of epidermal growth factor to stimulate the 
phosphorylation of the 250-kD protein (19).  WGA inhibited 
the  epidermal growth  factor-stimulated phosphorylation of 
the 250-kD protein, although not as much as NGF did (data 
not shown). This result is probably due to binding of WGA 
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FIGURE  2  Dose-dependence of WGA inhibition of the phospho- 
rylation of a 250-kD cytoskeletal protein. PC12 cells were incubated 
for 30 min at 37°C with the indicated concentrations of WGA, then 
50 ng/ml of NGF was added and incubated for 5 min more at 37°C. 
Cytoskeletons prepared from these cells were incubated with [3zp]_ 
ATP  for  10  min  at 4°C,  and  the  labeled phosphoproteins were 
separated by gel electrophoresis. The radioactivity in the 250-kO 
protein was determined by excision of the band and measurement 
by scintillation countin  8. The data are the mean of duplicate deter- 
minations and are representative of two independent experiments. 
NGF stimulated the incorporation of 320 cpm 32p into the 250-kD 
protein in the absence of WGA. FIGURE  3  Effect  of WGA on  NGF-induced changes  in  cell surface  morphology of PC12 cells.  PC12 cells  were incubated (a) 
alone; (b) in the presence of 50 ng/ml NGF for 3 min; (c) with 50 ~g/ml WGA for 30 rnin at 37°C; (d) with 50 ~g/ml WGA for 30 
rain at 37°C and then incubated for 3 min with 50 ng/ml NGF. Bar, 1 /~m. 
is paradoxical since the "slow" form of the NGF receptor is 
likely to be responsible for internalization of the hormone (8) 
and initiation  of many of its biological effects. The present 
data indicate that the association of the NGF receptor with 
the cytoskeleton, the acquisition of trypsin resistance, and the 
"slow" rate of ligand dissociation from the receptor are not of 
themselves directly involved in  the  signal transduction  that 
leads to initiation of the biological responses examined here. 
These alterations may involve the association of the receptor 
with other receptors or with membrane glycoproteins; indeed, 
the "slow" form of the receptor was reported to have a greater 
molecular mass than did the "fast" form (13, 23). It is apparent 
that the binding of ligand to the receptor induces a  confor- 
mational  change,  resulting  in  a  diminished  rate  of NGF 
dissociation and in resistance to trypsin (4,  14-16).  Whereas 
NGF can produce these changes through its specific associa- 
tion  with  the  receptor-binding  domain,  WGA  binding  at 
different sites produces similar effects. Furthermore, Vale and 
Shooter have reported that cross-linking the NGF receptors 
with antibodies can elicit identical changes (14). 
We interpret these data to indicate that the NGF receptor, 
upon binding of the hormone,  undergoes a  conformational 
change  that  alters  its  affinity  for  NGF.  This  alteration  is 
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accompanied by sequestration of trypsin-sensitive sites on the 
receptor and the  binding of the  hormone-receptor complex 
to the cytoskeleton. Similarly, WGA can produce an analo- 
gous conformational change, leading to trypsin resistance and 
altered NGF affinity; however, it is plausible that the tetra- 
valent lectin may immobilize the receptor by cross-linking to 
other  membrane  constituents.  Alternatively,  the  WGA-in- 
duced conformational change may be distinct from that pro- 
duced from NGF, as Grob and Bothwell suggested (15).  In 
either case, the NGF receptor cannot undergo physiologically 
relevant interactions, blocking the ability of NGF to produce 
its biological effects on the cells. 
One effect of preincubation  of the cells  with  WGA is to 
diminish  the binding of NGF to  PC12  cells  by -50%  (14, 
15). The experiments were performed at NGF concentrations 
of 50  ng/ml,  a  condition  under  which  the  level  of NGF 
receptor occupancy on  the  PCI2  cells,  even if reduced  by 
50%, would be more than sufficient to stimulate maximally 
each of the biological effects examined here. Both the NGF- 
stimulated neurite outgrowth and the phosphorylation of the 
250-kD cytoskeletal protein occur maximally at NGF concen- 
trations below 1 ng/ml (18,  19). The NGF-mediated alteration 
of cell  surface  morphology  is  also  observed  at  low  NGF 
Wheat Germ Agglutinin Blocks Nerve Growth Factor  Action  1693 concentrations  (24).  Thus,  the  inhibition  of the  biological 
response  of the  cells  to  NGF  was  not  a  consequence  of 
insufficient receptor occupancy. 
The dose of WGA required for half-maximal inhibition of 
NGF  action  was  <5  pg/ml.  The  effect  of WGA  on NGF 
binding was half-maximal at WGA concentrations of ~30- 
50 #g/ml, which suggests that the inhibition of the effect of 
NGF on these cells may occur at doses of WGA below that 
required to maximally inhibit NGF binding (14,  15). 
We have chosen to examine three different effects of NGF 
on PC12 cells,  two of which occur as an immediate conse- 
quence of receptor occupancy. The extension of neurites from 
these cells requires longer periods (1-2 d). Thus, WGA acts 
both acutely and chronically to block the receptor-mediated 
events that lead to the biological effects of NGF on these cells. 
The  molecular  mechanism  by  which  WGA  inhibits  NGF 
action is still  unclear, yet these observations provide insight 
into receptor mediation of the biological effects of NGF. 
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